MARISSA PIERCE: Open Payments
NPI 1841749595 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$245 in 13 payments from 9 companies in 2025. Trend: 2023 $243 · 2024 $441 · 2025 $245
Food & beverage: $245
| Company | Payments | Amount |
|---|---|---|
| Exact Sciences Corporation | 3 | $65 |
| Lilly USA, LLC | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Abbott Laboratories | 1 | $22 |
| ABBVIE INC. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| PFIZER INC. | 1 | $16 |
| Novo Nordisk Inc | 1 | $15 |
Products named: The Cologuard Plus Collection Kit, MOUNJARO, FARXIGA, FREESTYLE LIBRE 3, Cologuard Collection Kit, VRAYLAR, REXULTI, SHINGRIX.
Industry payments across TX — which companies pay providers there.
